Advent of technology and improved understanding of micro-organisms functions and benefits is expected to increase their applications

Google+ Pinterest LinkedIn Tumblr +

Industrial Microbiology involves commercial use of micro-organisms in various industrial processes such as fermentation. Use of micro-organisms for production processes has been in use since 18th century and was facilitated by discovery of various microorganisms over the years. Depending on nature of process, the industrial microbiology has two aspects, namely production of microbial products through fermentation processes and use of microorganisms for services, such as pollution control, to curb the contamination, and waste treatment. Microbial products produced using microbiology include bread, beer, cheese, enzymes, energy sources, food ingredients, and pharmaceuticals. Pharmaceutical industries require sterile environments, especially, injectable manufacturing plants as injectable products interfere directly with the circulatory system, where microbiology plays an important role. Second aspect of the industrial microbiology is employed for pollution control and restricting and creating microbial free environment. Micro-organisms can degrade all natural and man-made products making it easy to create pollution and contamination free environment. Products manufactured using microbiology include food, beverages, food additives and supplements, antibiotics, microbial enzymes, industrial chemical, and fuels.

To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/981

Advent of technology and improved understanding of micro-organisms functions and benefits is expected to increase their applications

Advances in fields of Recombinant DNA technology, use of microorganisms in treating diseases, rising prevalence of various bacterial, and viral infections globally is expected to boost the growth of industrial microbiology market with respect to pharmaceutical industry. Use of microorganisms in manufacturing various improvised vaccines for existing as well new infectious diseases is supporting the market growth. Cosmetic industry is growing, owing to the factors, such as evolving lifestyles, increasing demand for aesthetic life fulfilled by various offerings from the industry such as color cosmetics and skin care. Furthermore, in cosmetic industry, raw materials need to be thoroughly tested for any microbial contamination before further processing according to the Food & Drug Administration (FDA). These factors are expected to further propel the use of microbiological testing for cosmetic product safety. Diabetes, a potential life-threatening disease with no cure available, was affecting 30.3 Mn people in the U.S. out if which 1.25 Mn were suffering from type 1 diabetes in 2015 according to American Diabetes Association. Insulin is manufactured by using Recombinant DNA technology, which is a necessity for type 1 diabetes patients and with advances in the technology such as artificial chromosomes, automated DNA sequencing, and the use of microbiology in this area is expected to support the market growth over the forecast period.

Some major players operating in the industrial microbiology market include Merck KGaA, bioMérieux SA, Thermo Fisher Scientific Inc., Eppendorf AG, Bruker, Sartorius AG, QIAGEN, Becton Dickinson and Company, Bio-Rad Laboratories Inc., and Mettler-Toledo International Inc.

Quality control in pharmaceutical and food industry is of paramount importance, as healthcare is directly associated with the products from these industries. Microbial contamination in injectable, eye drops, drugs, nasal solutions, and food industries can be prevented with the help of micro-organisms by using various tests such as bio burden and growth promotion tests. According to the World Health Organization (WHO), unsafe food contaminated with harmful bacteria, parasites, and viruses can cause more than 200 diseases from diarrhea to cancers. Furthermore, food contamination has cost around 33 Mn of healthy life years according to the WHO. Microorganisms offer properties, such as rapid multiplication and growth rate, biodiversity, great shelf life, and use of byproducts after microbial process is finished, which saves time and cost for various industries. The field has advanced over years with inventions, such as microscope and increasing knowledge about microbial genetic makeup and biological processes associated with microorganisms. The technological advancements have made it possible to harness this knowledge into industrial microbiology. Application of microorganisms in bioremediation is expected to boost the growth of industrial microbiology market. Bioremediation is an important sector, which uses microorganisms to neutralize pollutants from a contaminated site. Industrial contamination is an ever growing issue where bioremediation has proven to be effective. The companies providing industrial microbiology solutions offer various products and services, such as quality control tests, equipment’s and systems, biomass conversion products for bioremediation, reaction consumables, and laboratory equipment.

Click here to know more about this report: https://www.coherentmarketinsights.com/market-insight/industrial-microbiology-market-981

Advent of technology and improved understanding of micro-organisms functions and benefits is expected to increase their applications

Advances in fields of Recombinant DNA technology, use of microorganisms in treating diseases, rising prevalence of various bacterial, and viral infections globally is expected to boost the growth of industrial microbiology market with respect to pharmaceutical industry. Use of microorganisms in manufacturing various improvised vaccines for existing as well new infectious diseases is supporting the market growth. Cosmetic industry is growing, owing to the factors, such as evolving lifestyles, increasing demand for aesthetic life fulfilled by various offerings from the industry such as color cosmetics and skin care. Furthermore, in cosmetic industry, raw materials need to be thoroughly tested for any microbial contamination before further processing according to the Food & Drug Administration (FDA). These factors are expected to further propel the use of microbiological testing for cosmetic product safety. Diabetes, a potential life-threatening disease with no cure available, was affecting 30.3 Mn people in the U.S. out if which 1.25 Mn were suffering from type 1 diabetes in 2015 according to American Diabetes Association. Insulin is manufactured by using Recombinant DNA technology, which is a necessity for type 1 diabetes patients and with advances in the technology such as artificial chromosomes, automated DNA sequencing, and the use of microbiology in this area is expected to support the market growth over the forecast period.

Some major players operating in the industrial microbiology market include Merck KGaA, bioMérieux SA, Thermo Fisher Scientific Inc., Eppendorf AG, Bruker, Sartorius AG, QIAGEN, Becton Dickinson and Company, Bio-Rad Laboratories Inc., and Mettler-Toledo International Inc.

Share.

About Author

Is an excellent researcher with expertise in the healthcare domain. His detailed research on topics related to recent breakthroughs in the genetic engineering, pharmacy, and healthcare fields coupled with his ability to concise his in-depth study in the best way possible, is of great advantage to this new portal. Contact Author

Comments are closed.